| Literature DB >> 34370572 |
Sam Horwich-Scholefield1, Tyler Lloyd2, Vici Varghese2, Emily Yette1, Sandra Huang1, Mark Pandori3.
Abstract
Laboratories submit all carbapenem-resistant Enterobacter, Escherichia coli, and Klebsiella species to the Alameda County Public Health Department (ACPHD). ACPHD evaluated 75 isolates submitted during 9 months for susceptibility to imipenem-relebactam (I-R) and, using whole-genome sequencing, identified β-lactamase genes. Of 60 (80%) isolates susceptible to I-R, 8 (13%) had detectable carbapenemase genes, including 4 KPC, two NDM, and two OXA-48-like; we described the relationship between the presence of β-lactamase resistance genes and susceptibility to I-R.Entities:
Keywords: NDM; carbapenem resistance; imipenem-relebactam; whole-genome sequencing; β-lactamase inhibitor
Mesh:
Substances:
Year: 2021 PMID: 34370572 PMCID: PMC8522770 DOI: 10.1128/AAC.02288-20
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191